Just realised this faster infusion trial is at lower dose, so unlikely to solve the poor plasma concentration issue.
Would make for a more user friendly UTI treatment though. And if the UTI culture comes back as Pseudomonas, they could switch to the 6,000mg 1 hour infusion to really crank up the urine 327 concentration.
Ann: Scientia Doses Ahead of Schedule in Phase I/II UTI Trial, page-3
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
47.0¢ |
Change
-0.010(2.08%) |
Mkt cap ! $95.87M | |||
| Open | High | Low | Value | Volume |
| 48.0¢ | 48.0¢ | 47.0¢ | $11.01K | 23.19K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 160499 | 47.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 48.0¢ | 32028 | 3 |
View Market Depth
| Last trade - 15.56pm 04/07/2024 (20 minute delay) ? |
| RCE (ASX) Chart |